## RKLB: Rocket Lab Corporation - XLI: Industrials

### Executive Summary

PARABOLIC warning: MRS_20 at 40.3% exceeds exhaustion threshold (10.0%). Extreme momentum typically precedes mean reversion. Consider profit-taking or tight stops.

- **Horizon:** 1-5 days (momentum)
- **Risk Profile:** High - extreme momentum reversal risk
- **Stop Type:** Fixed 2xATR ($66.72)
- **If Wrong:** Exit on momentum reversal or stop hit
- **Invalidation:** MRS_20 drops below exhaustion threshold

### News

- **Articles:** 7
- **Sentiment:** Bullish (Bullish: 7, Bearish: 0)

**1. Rocket Lab (RKLB) Stock News Today: $816M Space Force Satellite Win, Record Electron Launches, and Analyst Forecasts (Dec. 22, 2025)**
- Source: ts2.tech | 20251222T130951 | Bullish | Relevance: 100%
- Rocket Lab (RKLB) has seen significant momentum due to an $816 million Space Development Agency contract for satellites and a record 21 Electron launches in 2025 with 100% mission success. This "double catalyst" highlights Rocket Lab's pivot from solely a launch provider to a vertically integrated space systems and national security contractor. While analysts are largely bullish on its trajectory and the potential of its Neutron rocket, the stock's rapid price surge means current targets are being re-evaluated, and future performance will hinge on execution, profitability, and Neutron's development milestones.

**2. Rocket Lab Stock (RKLB) Week Ahead: Record Close After $816M Space Force Satellite Deal—Catalysts, Forecasts, and Key Risks to Watch**
- Source: ts2.tech | 20251222T130951 | Bullish | Relevance: 100%
- Rocket Lab (RKLB) stock is heading into a holiday-shortened trading week after a significant surge, closing at a record high of $70.52. This rally was driven by an $816 million contract with the U.S. Space Development Agency for satellite manufacturing and strong launch performance. The week ahead will focus on analyst reactions, further contract details, and updates on its Neutron rocket, which remains a key long-term driver and potential source of volatility for RKLB.

**3. Rocket Lab Stock (RKLB) Soars on $816M Contract Win, Announces 21st Electron Launch**
- Source: TipRanks | 20251222T130951 | Bullish | Relevance: 100%
- Rocket Lab (RKLB) stock surged 11% after announcing an $816 million contract with the U.S. Space Development Agency to build a missile-defense satellite constellation, its largest contract to date. This new contract, combined with a previous $515 million award, brings Rocket Lab's total SDA contract value to over $1.3 billion. The company also successfully launched its 21st Electron rocket of the year, deploying a satellite for iQPS, and plans five more launches for iQPS from 2026.

**4. Rocket Lab Successfully Launches for iQPS, Ends 2025 with 21 Launches and 100% Mission Success**
- Source: GlobeNewswire | 20251221T140906 | Bullish | Relevance: 100%
- Rocket Lab has successfully completed its 21st Electron rocket launch of the year for iQPS, a Japan-based Earth imaging company, deploying the QPS-SAR-15 satellite. This mission, named ‘The Wisdom God Guides,’ marks a new annual launch record for Electron with a 100% mission success rate, solidifying its position as a leading small launch provider. Rocket Lab plans further launches for iQPS and anticipates expanding Electron's global reach in 2026 for various civil, international, and defense applications.

**5. This small rocket just flew 21 times in a year without a miss**
- Source: Stock Titan | 20251221T130951 | Bullish | Relevance: 100%
- Rocket Lab (Nasdaq: RKLB) successfully completed its 21st Electron launch of 2025 on December 21, deploying QPS-SAR-15 for iQPS and achieving a 100% mission success rate for the year. This mission, "The Wisdom God Guides," marked a new annual launch record for Electron, reinforcing its position as a leading small-lift orbital rocket provider. The remarkable performance led to a nearly 10% gain in RKLB stock on the news.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 2, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-23 | Needham | $90 | $63 | +43% |
| 2025-12-22 | Stifel | $85 | $75 | +13% |
| 2025-11-25 | Needham | $63 | $63 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-23 | Needham | main | Buy |
| 2025-12-22 | Stifel | main | Buy |
| 2025-11-25 | Needham | reit | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 1 ($0.00M) |
| Sells | 12 ($27.76M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 29.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 7.8% (+5.4%)
- Blackrock Inc.: 5.9% (+38.0%)
- Capital World Invest: 2.7% (+9.4%)
- State Street Corpora: 2.3% (+13.6%)
- BAILLIE GIFFORD & CO: 2.3% (+176.1%)

### Key Risks

1. High beta (2.21) amplifies market volatility - any risk-off move could trigger sharp selloff.
2. Heavy insider selling: $28M sold (12 transactions in 90 days).
3. Elevated short interest (9.6%): bears positioning against stock.

### Catalysts

- Momentum building: MRS_20 improving +26.7% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.45 suggests fair value with growth premium. Balance sheet: strong liquidity (3.2x). Revenue growth strong at 47% YoY. Analyst sentiment positive (2 raises, avg +28%). Insider selling cluster ($27.8M in 90 days), potential headwind. Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $41.2B |
| Beta | 2.21 |
| 52W Range | $14.71 - $79.18 |
| Short Interest | 9.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.45 |
| Forward P/E | N/A |
| Current P/E | N/A |
| YoY Growth | N/A |
| EPS Direction | None |

### Technicals

MRS_20 strengthening from 13.6% to 40.3% (+26.7% in 5 days), confirming momentum buildup. Extended beyond STRENGTH zone (40.3% > 10.0%), caution on chasing. MRS_5 at 12.2% confirms short-term momentum alignment. AM_20 at 41.7% shows strong absolute momentum above own 20MA. Outperforming sector by 39.6pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (3.00), confirming momentum. RSI overbought at 74, risk of mean reversion. Elevated volume (2.0x 20MA), institutional activity likely. OFD pattern: +MUN (Resistance test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 40.28% (CS: 100) | Strong |
| RSI_14 | 74.0 | Overbought |
| MACD Histogram | 3.00 | Bullish |
| vs SMA20 | 1.417x | Above |
| vs SMA50 | 1.392x | Above |
| vs SMA200 | 1.927x | Above |

### Decision

- **Verdict:** SELL
- **Thesis:** PARABOLIC

### Trade Setup

- **Entry:** $77.18
- **Stop Loss:** $66.72 (13.6% risk)
- **Target:** $87.64 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** PARABOLIC thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 86
- **Position Value:** $6,637.48
- **Portfolio %:** 6.64%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with moderate risk appetite in holiday-thinned conditions. VIX at 52-week lows suggests complacency, but modest breadth improvement and stable yields indicate underlying stability. Focus on quality positioning ahead of 2026 catalysts.*

### Earnings

**Next:** 2026-02-26 (Est: $-0.10)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $-0.10 | $-0.03 | +71.3% |
| 2025Q2 | $-0.11 | $-0.13 | -17.9% |
| 2025Q1 | $-0.12 | $-0.12 | +0.5% |
| 2024Q4 | $-0.10 | $-0.10 | -2.2% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_20*